Nuclear factor kappa B (NF-KB): A novel cause for diabetes, coronary artery disease and cancer initiation and promotion?

被引:40
作者
Rial, Nathaniel S. [1 ]
Choi, Kwan [1 ]
Tam Nguyen [1 ]
Snyder, Branden [1 ]
Slepian, Marvin J. [1 ]
机构
[1] Univ Arizona, Dept Internal Med, Tucson, AZ 85724 USA
关键词
HEART-DISEASE; CELL LYMPHOMA; CARDIOVASCULAR-DISEASE; COLON-CANCER; INFLAMMATION; ATHEROSCLEROSIS; METASTASIS; CHEMOPREVENTION; CARCINOGENESIS; CHEMOKINES;
D O I
10.1016/j.mehy.2011.09.034
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Obesity is a growing epidemic in the United States (US). Obesity has been recognized as a modifiable risk factor for many diverse diseases including diabetes, cardiovascular disease and cancer burden. Common contributors to obesity include a high fat diet, smoking and physical inactivity. Systemic effects of obesity include increased micro-inflammatory molecules such as nuclear factor kappa B (NF-kappa B) that influence the both endothelial and epithelial layers as well as the supportive stroma. An emerging risk factor for micro-inflammation also includes periodontal disease. These pro-inflammatory states are hypothesized to contribute to diabetes as well as cardiovascular disease and cancer through the direct activation of NF-kappa B. Therefore, a comprehensive health care strategy would include reduction of diabetes, cardiovascular and cancer risk through the decrease in micro-inflammation. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:29 / 32
页数:4
相关论文
共 42 条
[1]   Chemokines: novel targets for breast cancer metastasis [J].
Ali, Simi ;
Lazennec, Gwendal .
CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) :401-420
[2]   Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].
Annunziata, Christina M. ;
Davis, R. Eric ;
Demchenko, Yulia ;
Bellamy, William ;
Gabrea, Ana ;
Zhan, Fenghuang ;
Lenz, Georg ;
Hanamura, Ichiro ;
Wright, George ;
Xiao, Wenming ;
Dave, Sandeep ;
Hurt, Elaine M. ;
Tan, Bruce ;
Zhao, Hong ;
Stephens, Owen ;
Santra, Madhumita ;
Williams, David R. ;
Dang, Lenny ;
Barlogie, Bart ;
Shaughnessy, John D., Jr. ;
Kuehl, W. Michael ;
Staudt, Louis M. .
CANCER CELL, 2007, 12 (02) :115-130
[3]  
[Anonymous], CANC STAT 2009
[4]  
[Anonymous], CANC FACT SHEET 2006
[5]   Epicardial Adipose Tissue as a Source of Nuclear Factor-κB and c-Jun N-Terminal Kinase Mediated Inflammation in Patients with Coronary Artery Disease [J].
Baker, A. R. ;
Harte, A. L. ;
Howell, N. ;
Pritlove, D. C. ;
Ranasinghe, A. M. ;
da Silva, N. F. ;
Youssef, E. M. ;
Khunti, K. ;
Davies, M. J. ;
Bonser, R. S. ;
Kumar, S. ;
Pagano, D. ;
McTernan, P. G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) :261-267
[6]   NF-κB, Inflammation, and Metabolic Disease [J].
Baker, Rebecca G. ;
Hayden, Matthew S. ;
Ghosh, Sankar .
CELL METABOLISM, 2011, 13 (01) :11-22
[7]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[8]   Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells [J].
Davis, RE ;
Brown, KD ;
Siebenlist, U ;
Staudt, LM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (12) :1861-1874
[9]   Type 2 diabetes as an inflammatory disease [J].
Donath, Marc Y. ;
Shoelson, Steven E. .
NATURE REVIEWS IMMUNOLOGY, 2011, 11 (02) :98-107
[10]   THE CANDIDATE ONCOPROTEIN BCL-3 IS AN ANTAGONIST OF P50/NF-KAPPA-B-MEDIATED INHIBITION [J].
FRANZOSO, G ;
BOURS, V ;
PARK, S ;
TOMITAYAMAGUCHI, M ;
KELLY, K ;
SIEBENLIST, U .
NATURE, 1992, 359 (6393) :339-342